Skip to content

Application of the G-Protein Biased Receptor Agonist Oliceridine in Gynecological Surgery: A Series of Studies Based on the ERAS Concept

Application of the G-Protein Biased Receptor Agonist Oliceridine in Gynecological Surgery: A Series of Studies Based on the ERAS Concept

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096799
Enrollment
Unknown
Registered
2025-02-06
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for gynecological surgery

Interventions

Sponsors

Second Xiangya Hospital of CSU
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Female, aged 18-65 years, ASA classification I-II, BMI 18-30 kg/m^2, scheduled for gynecological hysteroscopic or laparoscopic surgery;

Exclusion criteria

Exclusion criteria: 1.Severe dysfunction of major organs such as the heart, lungs, or brain; 2.history of allergy to opioids, propofol, soy, or eggs; 3.recent use of sedatives, analgesics, or monoamine oxidase inhibitors; 4.history of alcohol abuse; 5.obstructive sleep apnea, difficult airway; 6.psychiatric or neurological disorders, communication disorders; 7.breastfeeding or pregnant women;

Design outcomes

Primary

MeasureTime frame
PONV;

Secondary

MeasureTime frame
General information of the patient;Indicators during operation;postoperative;

Countries

China

Contacts

Public Contactxiao yanying

Second Xiangya Hospital of CSU

xiaoyanying192@163.com+86 731 85295973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026